BioPharma Leaders to Discuss Development and Manufacturing at Veeva Summit in Madrid

Biopharma leaders to connect at Veeva R&D and Quality Summit Europe, featuring presentations from Bayer, Lonza, MSD, Novo Nordisk, Recipharm, and Teva. The summit will focus on optimizing new drug development using connected platforms and AI. Veeva AI, an initiative to integrate AI into Veeva Vault and applications, will be highlighted.

Biopharma leaders will gather at the Veeva R&D and Quality Summit Europe, scheduled for June 4-5 in Madrid, Spain, to explore advancements in drug development and manufacturing. The event will feature keynote presentations from prominent biopharma companies including Bayer, Lonza, MSD, Novo Nordisk, Recipharm, and Teva. These leaders will discuss how connected platforms and AI are streamlining the development of new medicines [1].

The summit will bring together over 1,400 industry professionals across more than 100 sessions. The opening keynote will highlight Veeva AI, an initiative to integrate AI into the Veeva Vault Platform and Veeva applications, aiming to automate critical functions and enhance productivity [1]. Novo Nordisk and Recipharm will join Rik Van Mol, senior vice president of R&D and Quality, and Avril England, general manager of Veeva Vault, to explore the development and manufacturing of new medicines and therapies [1].

Speakers from Bayer, Lonza, MSD, Novo Nordisk, and Teva will share insights on their respective strategies. Bayer will discuss streamlining its clinical infrastructure with a customer-centric approach, while Lonza, a leading CDMO, will share how the evolving industry ecosystem is reshaping quality management across partners [1]. MSD will highlight innovations in pharmacovigilance operations and improving efficiency by building a trusted data foundation. Novo Nordisk will share how it accelerates clinical trials and launches by uniting business and IT on Veeva Development Cloud. Teva will emphasize innovation, agility, and a data-driven mindset in navigating regulatory change and driving efficiency [1].

"Fresh thinking and a strong community are essential to transforming how we bring medicines to patients," says Rik Van Mol. "At Veeva R&D and Quality Summit, leaders come together to spark new ideas, share breakthroughs, and shape the future of the industry together" [1].

The summit is open exclusively to life sciences professionals. Register and review the agenda at [Veeva Systems](https://veeva.com/eu/Summit).

References:
[1] https://www.prnewswire.com/news-releases/biopharma-leaders-connect-to-advance-development-and-manufacturing-at-veeva-rd-and-quality-summit-europe-302465193.html